Vir Biotechnology (VIR) Short Interest
Nasdaq • VIR • US92764N1028
As of Oct 22, 2026, ORTEX estimated 11.2% of free float sold short, 7.6 days to cover, cost to borrow 0.49%. Sign up for live short interest data.
Nasdaq • VIR • US92764N1028
As of Oct 22, 2026, ORTEX estimated 11.2% of free float sold short, 7.6 days to cover, cost to borrow 0.49%. Sign up for live short interest data.
This page tracks how heavily Vir Biotechnology (Nasdaq:VIR) is being shorted: ORTEX's daily short interest estimate, the cost to borrow the shares, utilization of the lendable supply and days to cover, next to the official exchange-reported figure.
Source: ORTEX. Some figures are limited on the free view; live data and full history are part of ORTEX Advanced.
Vir Biotechnology (Nasdaq: VIR) has a market capitalization of $2.09B. Last close $12.21 (as of 2026-11-09); 52-week range $4.82 to $12.45. ORTEX data as of 2026-10-22: short interest was 11.19% of free float, 7.6 days to cover and the average cost to borrow was 0.49%. Sign up for live short interest data.